Latest News about IKT

Recent news which mentions IKT

< Previous 1 2 3 Next >

Why Chimerix Is Trading Higher By Over 19%, Here Are 53 Stocks Moving In Monday's Mid-Day Session

August 29, 2022

Why Hill International Is Trading Higher By 15%; Here Are 30 Stocks Moving Premarket

August 29, 2022

Recap Of Friday's Biotech Catalysts - End Of the Day Summary

August 26, 2022

Inhibikase Shares Shoot Higher As FDA Announced Clearance To Blood-Cell Cancer Study

August 26, 2022

This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday

August 16, 2022

Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday's Mid-Day Session

August 15, 2022

Inhibikase Therapeutics: Q2 Earnings Insights

August 12, 2022

Earnings Scheduled For August 12, 2022

August 12, 2022

Earnings Preview: Inhibikase Therapeutics

August 11, 2022

24 Stocks Moving in Wednesday's Pre-Market Session

June 15, 2022

Recap: Inhibikase Therapeutics Q1 Earnings

May 16, 2022

Earnings Scheduled For May 16, 2022

May 16, 2022

Inhibikase Therapeutics's Return On Capital Employed Overview

April 01, 2022

The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall

March 31, 2022

Earnings Scheduled For March 31, 2022

March 31, 2022

Earnings Outlook For Inhibikase Therapeutics

March 30, 2022

The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict

March 30, 2022

The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More

March 27, 2022

The Daily Biotech Pulse: Moderna Files For 2nd COVID Booster Shot Authorization, Lexicon Secures Debt Funding, Amneal Gets Sub-License to Manufacture Generic COVID Pill

March 18, 2022

The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings

March 13, 2022

48 Biggest Movers From Yesterday

January 12, 2022

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results

October 07, 2021

Inhibikase Shares Interim 3-Month Toxicology Studies Data Of Parkinson's Candidate

October 04, 2021

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business

August 17, 2021

The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO

August 13, 2021

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal

July 28, 2021

The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts

July 27, 2021

Inhibikase To Start Testing Its Parkinson's Candidate In Patients

July 26, 2021

The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street

July 20, 2021

The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs

July 15, 2021

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.